EEF1A2 and carcinoma: Moreover the application is not limited to a certain cancer type, because lectin binding is not limited to a specific glycopeptide and the addressed glycans Tn- and STn-antigen are expressed in multiple carcinomas making the CAR applicable to the appropriate cancer entities.